A recent story by Lori Solomon on HealthDay.com describes new data showing higher rates of psych drugs dispensed to kids with Type 1 diabetes compared with those without:
“Dispensing of psychotropic medication increased among children and adolescents with type 1 diabetes (T1D) from 2006 to 2019, according to a study published online Oct. 3 in JAMA Network Open.
Shengxin Liu, from the Karolinska Institutet in Solna, Sweden, and colleagues examined trends and patterns of psychotropic medication dispensing among 13,200 children and adolescents with T1D in Sweden between 2006 and 2019. Trends were compared to those among more than 3.7 million children in the general population without T1D.
The researchers found that psychotropic medication dispensing increased from 0.85 to 3.84 percent among children and from 2.72 to 13.54 percent among adolescents with T1D, consistently higher than their peers without T1D. Hypnotics, attention-deficit/hyperactivity disorder medications, anxiolytics, and selective serotonin reuptake inhibitors were the most commonly dispensed medications, and all exhibited increasing trends. Psychiatric care was the primary prescription source among those with T1D, and up to 50.1 percent of treatments lasted more than 12 months..”
Article →
***
More from Around the Web
More from Mad in the Family
It’s concerning to see the rising use of psychotropic medications among children and teens with Type 1 diabetes. The correlation highlighted in this study underscores the importance of comprehensive care for young patients managing both physical and mental health challenges. Platforms like https://insulin.store/ are crucial for purchasing insulin from Canada, ensuring holistic support for these vulnerable populations. It’s essential that healthcare systems globally prioritize integrated approaches to manage the well-being of young people with chronic conditions like Type 1 diabetes, addressing both their physical and psychological needs effectively.
Report comment